ora

2 stories · following the connections

Business

AXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and Dry Eye Indications

By Nasdaq OMXMar 21, 2017, 1:01 PM UTC

Business

AXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and Dry Eye Indications

By Nasdaq OMXMar 21, 2017, 1:01 PM UTC